A report by Transparency Market Research finds that big international players in the global market for Nanoemulsion are keen to tap into the developing nations’ market that offer ample room for growth.
Some of the key players operating in the global market for Nanoemulsion are Mitsubishi Tanabe Pharma Corporation, Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, and B. Braun Melsungen AG. Many of them already have a robust pipeline of nanoemulsion based vaccines against influenza, anthrax, chlamydia infection, several sexually transmitted infections, and respiratory diseases.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15473
Buoyed by demand from both developed and developing nations, the TMR report projects the global Nanoemulsion market to rise at a 9.2% CAGR during the period between 2017 and 2025. Expanding at this pace, the market which was worth US$6.78 bn in 2016 will probably become worth US$14.91 bn by 2025.
Increasing Research Activities Boosts North America Market
Depending upon the type of drugs, the global market for Nanoemulsion can be segmented into steroids, anesthetics, NSAIDs, antiretroviral, antimicrobials, immunosuppressant, vasodilators, etc. Among them, the segment of NSAIDs will likely gain maximum share by outpacing all others vis-à-vis growth rate. By 2025, the segment of NSAIDs will rake in a revenue of US$2.470 bn. The high growth of the segment is due to the increasing use nanoemulsion formulation in topical and other drug administration routes for more efficient drug delivery allowing for rapid penetration.
Geography-wise, the key segments of the global market for Nonoemulsion are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA). Among them, North America held the leading share of 39.7% in 2016. The market in the region is predicted grow at a healthy clip in the upcoming years as well on account of the increasing demand generated by a well-established pharmaceutical and biotechnology industry, increasing research activities, increasing prevalence of chronic disorders, and increased demand for highly efficient drug delivery module for target specific treatment of disorders.
Emergence of Better Products Benefits Market
Serving to majorly fuel the global market for Nanoemulsion is the rapid technological progress in the pharmaceutical and biotechnology industry, rising instances of chronic diseases, increasing awareness about their treatments, growing demand for more target specific drug delivery systems, and supportive policies of governments. Emergence of technologically advanced new products is also having a positive impact on the global Nanoemulsion market.
The other factors responsible for the growth the market include increasing healthcare infrastructure, increasing economic stability, increasing participation of major market players in in developing economies such as Latin America and the Middle East and Africa. Increasing demand for more efficient drug delivery systems and increasing research and development is expected to drive the market during the forecast period.
“As the Nanoemulsions do not undergo flocculation or sedimentation they are ideal for use in baby-care wipes or make-up removal applications. This is another growth driver in the market. As nanoemulsions are non-toxic and non-irritant they are widely used in skin care cosmetics. However, the cost of nanoemulsions preparation can prove to be a deterrent to the nanoemulsions market,” explains the lead analyst of the report.